HEPATITIS B， CHRONIC
Clinical trials for HEPATITIS B， CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B， CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B， CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to tame hepatitis b in patients on antivirals
Disease control TerminatedThis study tested a new therapeutic vaccine (GSK3528869A) in adults aged 18-65 with chronic hepatitis B whose virus was already well-controlled by standard antiviral pills. The goal was to see if the vaccine could safely lower hepatitis B surface antigen levels and possibly allow…
Matched conditions: HEPATITIS B， CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Experimental hepatitis b drug shows promise in early trial
Disease control TerminatedThis study tested whether a new drug called ARC-520, given with the standard medicine entecavir, could lower hepatitis B virus levels in people with chronic hepatitis B. About 58 adults with different stages of infection received either ARC-520 or a placebo. The study was stopped…
Matched conditions: HEPATITIS B， CHRONIC
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
HepTcell hepatitis b vaccine trial ends early: what it means
Disease control TerminatedThis study tested a treatment called HepTcell, which is like a vaccine that trains the immune system to fight the hepatitis B virus. It was for people with inactive chronic hepatitis B who had not received treatment before. The goal was to see if it could lower virus levels or cl…
Matched conditions: HEPATITIS B， CHRONIC
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC